                         SEQUENCE LISTING

<110>  Advanced Solutions Life Sciences
 
<120>  Vascularized Organoid Model Incorporating Isolated Human 
       Microvessel Fragments

<130>  50772-239; AVN0081WO

<150>  63/089907
<151>  2020-10-09

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Adiponectin forward primer

<400>  1
aaggagatcc aggtcttatt gg                                                22


<210>  2
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Adiponectin reverse primer

<400>  2
accttcagcc ccgggtac                                                     18


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PPAR-gamma forward primer

<400>  3
cataaagtcc ttcccgctga                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PPAR-gamma reverse primer

<400>  4
gggggtgatg tgtttgaact                                                   20


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-6 forward primer

<400>  5
ggtacatcct cgacggcatc t                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-6 reverse primer

<400>  6
gtgcctcttt gctgctttca c                                                 21


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Insulin receptor forward primer

<400>  7
tgcaaaccca agaacgtcag                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Insulin receptor reverse primer

<400>  8
agcttccggg agttcagtac                                                   20


